# Addex Therapeutics Ltd.: Form 6-K, filed Jun 25, 2026

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 6-K
- Filed: 2026-06-25
- Accepted by EDGAR: Jun 25, 2026, 06:00 ET
- Period: 2026-06-25
- Accession: 0001104659-26-077470
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465926077470/tm2618934d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465926077470/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465926077470/tm2618934d1_6k.htm

Filed Jun 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-077470. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.